Daihan Pharmaceutical Co. Ltd. | Cash Flow
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
7,771
10,420
13,776
17,657
24,832
Depreciation, Depletion & Amortization
3,527
3,987
4,491
5,073
7,588
Funds from Operations
13,144
15,613
18,995
22,436
33,578
Changes in Working Capital
458
6,129
59
5,489
13,124
Net Operating Cash Flow
12,686
9,483
19,054
27,924
20,455
Capital Expenditures
19,220
10,477
3,962
21,898
21,047
Sale of Fixed Assets & Businesses
34
170
26
780
59
Purchase/Sale of Investments
289
1,433
77
2,602
214
Net Investing Cash Flow
19,969
11,858
4,927
23,718
20,767
Cash Dividends Paid - Total
361
720
900
1,080
1,320
Issuance/Reduction of Debt, Net
8,463
2,443
7,831
3,517
6,000
Net Financing Cash Flow
9,088
1,723
8,731
4,597
4,690
Net Change in Cash
1,788
611
5,524
505
4,266
Free Cash Flow
6,191
986
15,092
6,027
592
Deferred Taxes & Investment Tax Credit
273
707
523
642
515
Other Sources
419
844
460
94
7
Change in Capital Stock
996
-
-
-
-
Exchange Rate Effect
17
41
128
115
111
Other Uses
912
963
1,528
92
-
About Daihan Pharmaceutical Co.
View Profile
